Milestone Scientific (NYSE:MLSS) Trading Down 3.9% – What’s Next?

Milestone Scientific Inc. (NYSE:MLSS) dropped 3.9% during mid-day trading on Tuesday . The company traded as low as $0.45 and last traded at $0.4580. Approximately 69,306 shares were traded during trading, a decline of 92% from the average daily volume of 915,962 shares. The stock had previously closed at $0.4768.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MLSS. Morgan Stanley set a $1.00 price target on shares of Milestone Scientific in a report on Monday, August 17th. Benchmark reaffirmed a “speculative buy” rating on shares of Milestone Scientific in a research report on Monday, August 17th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $1.00.

Milestone Scientific Trading Up 1.1%

The company has a market capitalization of $41.61 million, a P/E ratio of -6.70 and a beta of 1.08. The company has a 50 day moving average price of $0.43 and a 200 day moving average price of $0.36.

Hedge Funds Weigh In On Milestone Scientific

A hedge fund recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. raised its stake in Milestone Scientific Inc. (NYSE:MLSS) by 416.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 62,000 shares of the company’s stock after buying an additional 50,000 shares during the period. Raymond James Financial Inc. owned about 0.08% of Milestone Scientific worth $39,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.